Cancer Research 2018: Cost effectiveness analysis of Cetuximab treatment of locally advanced head and neck cancer - Abdalla Abotaleb - World Health Organization, Egypt
model parameters, we performed various one-dimensional sensitivity analyses. Time horizon was estimated as 10 years. Results: After ten years, total QALYs for cetuximab plus radiotherapy group was estimated ... SCCHN…

